REGEN-COV Cuts Risk of Hospitalization, Death in High-Risk, Non-Hospitalized COVID-19 Patients

Retrieved on: 2021-03-23 20:15:00

Tags for this article:

Click the tags to see associated articles and topics

REGEN-COV Cuts Risk of Hospitalization, Death in High-Risk, Non-Hospitalized COVID-19 Patients. View article details on hiswai:

Excerpt

Positive topline data were announced from a phase 3 trial evaluating Regeneron's monoclonal antibody therapy, REGEN-COV™ (casirivimab with ...

Article found on: www.empr.com